Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 18 04:00PM ET
2.97
Dollar change
+0.01
Percentage change
0.34
%
Index- P/E- EPS (ttm)-0.68 Insider Own26.67% Shs Outstand5.68M Perf Week-0.34%
Market Cap17.23M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.25M Perf Month-4.81%
Income-3.90M PEG- EPS next Q- Inst Own22.32% Short Float0.27% Perf Quarter0.34%
Sales22.80M P/S0.76 EPS this Y- Inst Trans-1.30% Short Ratio0.86 Perf Half Y-23.65%
Book/sh1.28 P/B2.32 EPS next Y- ROA-22.54% Short Interest0.01M Perf Year-49.75%
Cash/sh0.24 P/C12.57 EPS next 5Y20.00% ROE-40.70% 52W Range2.06 - 6.13 Perf YTD0.34%
Dividend Est.- P/FCF- EPS past 5Y- ROI-44.73% 52W High-51.55% Beta0.68
Dividend TTM0.14 (4.71%) Quick Ratio1.46 Sales past 5Y-9.27% Gross Margin37.71% 52W Low44.17% ATR (14)0.18
Dividend Ex-DateMay 24, 2023 Current Ratio1.46 EPS Y/Y TTM-88.43% Oper. Margin-10.56% RSI (14)44.06 Volatility4.91% 6.35%
Employees133 Debt/Eq0.36 Sales Y/Y TTM-12.20% Profit Margin-17.09% Recom1.00 Target Price32.00
Option/ShortNo / Yes LT Debt/Eq0.17 EPS Q/Q-2020.35% Payout- Rel Volume0.28 Prev Close2.96
Sales Surprise- EPS Surprise- Sales Q/Q-12.46% Earnings- Avg Volume13.52K Price2.97
SMA20-2.42% SMA50-6.84% SMA200-17.36% Trades Volume3,798 Change0.34%
Jan-02-24 11:27AM
Nov-27-23 09:00AM
Nov-09-23 05:54PM
05:00PM
Oct-27-23 11:00AM
05:00PM Loading…
Sep-21-23 05:00PM
Aug-18-23 02:00PM
Aug-11-23 05:16PM
05:10PM
Jul-12-23 05:15PM
May-19-23 06:08AM
May-13-23 08:16AM
May-09-23 06:52PM
05:30PM
Apr-17-23 06:22AM
05:34PM Loading…
Mar-21-23 05:34PM
05:15PM
Nov-12-22 07:34AM
Nov-09-22 05:00PM
Nov-07-22 07:38AM
Aug-18-22 08:12AM
Aug-09-22 05:15PM
Jun-09-22 05:00PM
Jun-07-22 08:23AM
May-10-22 05:15PM
Apr-08-22 11:32AM
Mar-29-22 05:15PM
Mar-22-22 08:30AM
Feb-16-22 01:29PM
Dec-10-21 05:00PM
11:05AM Loading…
Nov-16-21 11:05AM
Nov-12-21 05:00PM
Aug-10-21 05:10PM
Jul-01-21 05:25AM
Jun-14-21 04:25PM
May-10-21 05:15PM
Mar-23-21 05:15PM
Mar-17-21 02:38PM
Jan-26-21 03:28PM
Jan-02-21 02:47AM
Dec-17-20 10:31AM
Nov-29-20 02:22PM
Nov-09-20 05:29PM
Aug-12-20 05:20PM
02:19PM
02:02PM
May-28-20 03:25PM
09:02AM
May-13-20 05:15PM
May-05-20 08:00AM
Apr-29-20 12:00PM
Apr-28-20 02:00PM
08:45AM
Apr-02-20 07:57AM
Mar-17-20 08:51AM
Feb-11-20 05:25PM
Jan-31-20 03:45PM
Jan-20-20 11:11AM
Dec-22-19 06:11PM
Dec-13-19 07:30AM
Dec-10-19 02:15PM
Nov-07-19 09:19AM
Oct-31-19 12:07PM
Oct-22-19 05:25PM
Oct-15-19 11:44AM
Sep-27-19 02:59PM
Sep-19-19 05:25PM
Sep-05-19 07:24AM
Aug-18-19 10:00AM
Jul-31-19 06:05AM
Jul-30-19 07:25AM
Jul-23-19 05:25PM
Jul-10-19 07:10AM
Jun-04-19 03:08PM
May-07-19 12:41PM
Apr-24-19 08:00AM
Apr-23-19 05:34PM
05:25PM
Apr-11-19 11:37AM
Mar-27-19 01:46PM
Mar-18-19 08:52AM
Mar-04-19 05:15PM
Feb-24-19 08:42AM
Feb-04-19 07:52AM
Jan-23-19 02:18PM
Nov-22-18 10:35AM
Nov-15-18 07:30AM
Nov-02-18 12:15PM
Oct-27-18 09:21AM
Oct-23-18 06:02PM
05:30PM
Oct-12-18 11:53AM
Sep-12-18 11:52AM
Jul-24-18 05:45PM
05:30PM
Jun-22-18 12:33PM
May-08-18 10:00AM
May-04-18 07:05AM
May-02-18 01:00PM
Apr-24-18 05:30PM
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Doucot Charles MExecutive Vice PresidentAug 17 '23Sale4.6612,70059,18223,250Aug 21 05:48 PM